Randomized split face trial suggests intradermal botulinum toxin A for post acne erythema reduces redness and sebum versus broadband light with similar short term safety.

VANCOUVER -- Guidelines for the use of botulinum toxin in various neurological disorders are getting an update, with the best evidence supporting the use of some formulations in spasticity and chronic ...

Market valued at USD 9.6B in 2023 and set to nearly double by 2032-propelled by non-invasive trends, digital outreach, and innovative therapeutic applications. This robust growth signals a pivotal ...

Explore Facial Aesthetics Market trends, key players, and $34.25 Billion forecast by 2032. CAGR 11.6% growth led by non-surgical demand. Dermal fillers and energy-based devices are key growth drivers, ...

DUBLIN--(BUSINESS WIRE)--The "Botulinum Toxin Market Size, Share & Trends Analysis Report By Type (Botulinum Toxin Type A, Botulinum Toxin Type B), By End Use (Therapeutic, Aesthetic), By Region, And ...

At least one Big Apple resident was among 10 people hospitalized with “severe” illness in the US after injecting Botox bought ...